Why do we need a selective angiotensin II type 2 receptor agonist?
Abstract
pas de résumé
Loading...
Daniel Henrion : Connect in order to contact the contributor
https://www.hal.inserm.fr/inserm-00768682
Submitted on : Saturday, December 22, 2012-9:22:55 PM
Last modification on : Wednesday, October 20, 2021-3:19:19 AM
Long-term archiving on: Sunday, December 18, 2016-10:09:32 AM